Sleep Apnea Syndrome: Prevalence and Comorbidity with Other Non-communicable Diseases and HIV Infection, among Hospitalized Patients in Yaoundé, Cameroon
Table 3
Frequencies of medical conditions (cardiovascular, metabolic, brain, and HIV infection) among patients with clinical sleep apnea syndrome, hospitalized in Yaoundé Central Hospital, November 2016–May 2017, Yaoundé, Cameroun. .
Medical conditions
Global sample
Overall SAS
Moderate to severe SAS
Yes ()
No ()
value
Yes ()
No ()
value
Cardiovascular
Hypertension
70 (63.1)
46 (75.4)
24 (48.0)
0.005
32 (84.2)
38 (52.1)
0.002
Cardiac failure
20 (18.3)
14 (23.0)
6 (12.0)
0.213
9 (23.1)
11 (15.1)
0.390
Global cardiovascular
75 (67.6)
49 (80.3)
26 (52.0)
0.003
34 (89.5)
41 (52.2)
˂0.001
Metabolic
Diabetes
49 (44.1)
28 (45.9)
21 (42.0)
0.826
14 (38.8)
35 (47.9)
0.359
Obesity
42 (37.8)
25 (41.0)
17 (34.0)
0.577
14 (36.8)
28 (38.4)
1
Renal failure
4 (3.6)
3 (4.9)
1 (2.0)
0.626
1 (2.6)
3 (4.1)
1
Global metabolic
71 (64.0)
42 (68.9)
29 (58.02)
0.324
22 (57.9)
49 (67.1)
0.452
Brain
Stroke ()
38 (34.5)
22 (36.7)
16 (32.0)
0.756
15 (40.5)
23 (31.5)
0.466
Moderate to severe depression ()
21 (20.8)
12 (20.7)
9 (20.9)
1.000
6 (17.1)
15 (22.7)
0.689
Significant anxiety ()
1 (1.0)
1 (1.8)
0 (0.0)
1.000
1 (2.8)
0 (0.0)
0.360
Epilepsy
5 (4.5)
2 (3.3)
3 (6.0)
0.656
2 (5.3)
3 (4.1)
1.000
Global brain
49 (44.1)
27 (44.3)
22 (44.0)
1.000
18 (47.4)
31 (42.5)
0.770
HIV infection
8 (7.2)
2 (3.3)
6 (12.0)
0.162
1 (2.6)
7 (9.6)
0.338
Data are expressed as numbers (frequency in %). SAS: sleep apnea syndrome. For comparison between groups, using Chi2, Chi2 with Yate’s correction or Fisher test.
